Memo to DOJ: Celexa Drug Maker Hid Mistakes, Harming Children

  • © Moira Dolan, MD

The Department of Justice (DOJ) is being asked to reopen investigations into the makers of Celexa (Forest, now owned by Allergan) for deliberately misleading the government. Earlier lawsuits in 2010 eventually resolved when Forest paid out a total of...

Read More

Marijuana: Death From Hypertension More Than Threefold Higher

  • © Moira Dolan, MD

A national poll and found marijuana users were 3.42 times more likely to die from hypertension than non-users. Twenty-one percent of adults over 20 were chronic users of marijuana, for an average duration of 11.5 years. Increased use of marijuana ...

Read More

1 in 6 Americans Are on Psych Drugs!

  • © Moira Dolan, MD

One out of every 6 Americans filled one or more psychiatric drug prescription in the previous 12 months, according to research that looked at 2013 survey data. The researchers figure that the true number is probably higher, as self-reports ar...

Read More

Feds Propose Easing the Way for More Electroshock

  • © Moira Dolan, MD

The Food and Drug Administration is quietly proposing changing the classification of electroshock (ECT) machines from the unproven, experimental category called “Class III” down to a less regulated “Class II” device. This subtle change opens ...

Read More

ADHD Drugs: Prescription Speed for Kids is Good for Pharma

  • © Moira Dolan, MD

$13 Billion Dollars: that is the annual revenue for pharmaceutical companies for drugs to treat ADHD.  There has been a 41% increase in the diagnosis of ADHD in the last decade. The facts are exposed in a series of articles on ADHD drugs in WIRED ma...

Read More

Paroxetine (Paxil, Seroxat) Drug Maker Suppressed Evidence of Suicidality

  • © Moira Dolan, MD

What happens when drug makers find out their products cause suicide, agitation and drug dependence?  The information gets suppressed and the drug is hailed as safe and effective, of course. An analysis of the raw data from paroxetine studies done...

Read More

Stay Informed. Join the Mailing List.

Close Menu